Our results clearly demonstrated a relatively higher expression level of CPEB4 in freshly prepared high-grade glioma tissue samples B430 (WHO III) and B315 (WHO IV) than in the low-grade glioma sample B099 (WHO I). The gene discussed is CPEB4; the disease is central nervous system cancer.